Weekly shot could replace daily insulin for diabetes
NCT ID NCT06767735
First seen Jan 05, 2026 · Last updated Jun 07, 2026 · Updated 29 times
Summary
This study tests a new once-weekly insulin (GZR4) against a standard daily insulin in adults with type 2 diabetes who have never used insulin before. About 580 participants will receive either the weekly shot plus other diabetes pills or the daily shot plus other pills. The goal is to see if the weekly option controls blood sugar just as well, with fewer injections and similar safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gan & Lee Pharmaceuticals Shandong Co., Ltd.
Linyi, Shandong, 276000, China
Conditions
Explore the condition pages connected to this study.